STRL vs. VRNA

Last updated Jun 9, 2026

STRL (Sterling Construction Company, Inc.) and VRNA (Verona Pharma plc) are both stocks. STRL operates in Engineering & Construction (Industrials), while VRNA operates in Biotechnology (Healthcare). At a 0.13 correlation, their price movements are largely independent.

Performance

STRL vs. VRNA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Sterling Construction Company, Inc. (STRL) and Verona Pharma plc (VRNA). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

STRL

• 1D: 1.07%
• 1M: 5.57%
• YTD: 191.24%
• 6M: 174.74%
• 1Y: 332.96%
• 3Y*: 155.47%
• 5Y*: 104.86%
• 10Y*: 68.46%

VRNA

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

STRL vs. VRNA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
STRL Sterling Construction Company, Inc.	191.24%	81.79%	91.57%	168.08%	24.71%	41.32%	32.17%	29.29%	-33.11%	71.37%
VRNA Verona Pharma plc	0.00%	130.21%	133.60%	-23.92%	288.84%	-4.00%	21.74%	-40.41%	-18.71%	-12.07%

Correlation

The correlation between STRL and VRNA is -0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.01
Correlation (3Y) Calculated over the trailing 3-year period	0.18
Correlation (5Y) Calculated over the trailing 5-year period	0.16
Correlation (All Time) Calculated using the full available price history since Apr 27, 2017	0.13

The correlation between STRL and VRNA shifts across timeframes, from -0.01 (1 year) to 0.18 (3 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap STRL : $27.68B VRNA : $9.72B
EPS STRL : $11.19 VRNA : -$0.69
PS Ratio STRL : 9.58 VRNA : 57.97
PB Ratio STRL : 23.27 VRNA : 34.92
Total Revenue (TTM) STRL : $2.88B VRNA : $167.65M
Gross Profit (TTM) STRL : $664.66M VRNA : $159.52M
EBITDA (TTM) STRL : $429.99M VRNA : -$40.86M

Return for Risk

STRL vs. VRNA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

STRL

STRL Risk / Return Rank: 97
STRL Sharpe Ratio Rank: 98
STRL Sortino Ratio Rank: 96
STRL Omega Ratio Rank: 95
STRL Calmar Ratio Rank: 98
STRL Martin Ratio Rank: 98

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

STRL vs. VRNA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Sterling Construction Company, Inc. (STRL) and Verona Pharma plc (VRNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	STRL	VRNA	Difference
Sharpe ratio: Return per unit of total volatility	4.13	—	—
Sortino ratio: Return per unit of downside risk	4.20	—	—
Omega ratio: Gain probability vs. loss probability	1.56	—	—
Calmar ratio: Return relative to maximum drawdown	10.82	—	—
Martin ratio: Return relative to average drawdown	30.19	—	—
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

Sharpe Ratios by Period

	STRL	VRNA	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	4.13	—	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	1.85	—	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	1.29	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.27	—	—

Drawdowns

Drawdown Indicators

	STRL	VRNA	Difference
Max Drawdown Largest peak-to-trough decline	-92.51%	—	—
Max Drawdown (1Y) Largest decline over 1 year	-31.02%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-47.67%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-47.67%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-59.60%	—	—
Current Drawdown Current decline from peak	-10.25%	—	—
Average Drawdown Average peak-to-trough decline	-46.31%	—	—
Ulcer Index Depth and duration of drawdowns from previous peaks	11.09%	—	—

Volatility

Volatility by Period

	STRL	VRNA	Difference
Volatility (1M) Calculated over the trailing 1-month period	24.22%	—	—
Volatility (6M) Calculated over the trailing 6-month period	63.81%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	81.49%	—	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	56.99%	—	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	53.42%	—	—

Dividends

STRL vs. VRNA - Dividend Comparison

Neither STRL nor VRNA has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

STRL vs. VRNA - Profitability Comparison

The chart below illustrates the profitability comparison between Sterling Construction Company, Inc. and Verona Pharma plc over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

STRL - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Sterling Construction Company, Inc. reported a gross profit of 194.30M and revenue of 825.68M. Therefore, the gross margin over that period was 23.5%.

VRNA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Verona Pharma plc reported a gross profit of 71.68M and revenue of 75.14M. Therefore, the gross margin over that period was 95.4%.

STRL - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Sterling Construction Company, Inc. reported an operating income of 2.36M and revenue of 825.68M, resulting in an operating margin of 0.3%.

VRNA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Verona Pharma plc reported an operating income of 9.69M and revenue of 75.14M, resulting in an operating margin of 12.9%.

STRL - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Sterling Construction Company, Inc. reported a net income of 95.97M and revenue of 825.68M, resulting in a net margin of 11.6%.

VRNA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Verona Pharma plc reported a net income of 8.69M and revenue of 75.14M, resulting in a net margin of 11.6%.

Frequently Asked Questions

Can I hold both STRL and VRNA in my portfolio?

STRL and VRNA have a correlation of -0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.